HB 0029A 2003
   
1 A bill to be entitled
2          An act relating to public records and public meetings
3    exemptions; amending s. 1004.445, F.S.; creating a public
4    records exemption for proprietary confidential business
5    information owned or controlled by the Florida Alzheimer's
6    Center and Research Institute; categorizing specified
7    types of information as proprietary confidential business
8    information; defining "managed care"; providing for access
9    to proprietary confidential business information by
10    specified agencies; creating a public meetings exemption
11    for specified meetings or portions of meetings of the
12    governing board of the Florida Alzheimer’s Center and
13    Research Institute; providing for future review and repeal
14    of the exemption; providing a statement of public
15    necessity; providing for construction of the act in pari
16    materia with laws enacted during the Regular Session of
17    the Legislature; providing an effective date.
18         
19          Be It Enacted by the Legislature of the State of Florida:
20         
21          Section 1. Subsection (9) of section 1004.445, Florida
22    Statutes, is amended, and subsection (10) is added to said
23    section, to read:
24          1004.445 Florida Alzheimer's Center and Research
25    Institute.--
26          (9)(a)The following information is confidential and
27    exempt from the provisions of s. 119.07(1) and s. 24(a), Art. I
28    of the State Constitution:
29          1.(a)Personal identifying information relating to clients
30    of programs created or funded through the Florida Alzheimer's
31    Center and Research Institute which is held by the institute,
32    the University of South Florida, or theState Board of Education
33    or by persons who provide services to clients of programs
34    created or funded through contracts with the Florida Alzheimer's
35    Center and Research Institute;
36          2.(b) Any medical or health records relating to patients
37    heldwhich may be created or received by the institute; and
38          3.(c)Proprietary confidential business information. As
39    used in this subparagraph, the term "proprietary confidential
40    business information” means information, regardless of its form
41    or characteristics, which is owned or controlled by the
42    institute; is intended to be and is treated by the institute as
43    private and the disclosure of which would harm the business
44    operations of the institute; has not been intentionally
45    disclosed by the institute unless pursuant to law, an order of a
46    court or administrative body, a legislative proceeding pursuant
47    to s. 5, Art. III of the State Constitution, or a private
48    agreement that provides that the information may be released to
49    the public; and which is information concerning:
50          a.Materials that relate to methods of manufacture or
51    production, potential trade secrets, potentially patentable
52    material, actual trade secrets as defined in s. 688.002, or
53    proprietary information received, generated, ascertained, or
54    discovered during the course of research conducted by or through
55    the institute and business transactions resulting from such
56    research;
57          b.(d) The identity of a donor or prospective donor to the
58    instituteFlorida Alzheimer's Center and Research Institutewho
59    wishes to remain anonymous, and all information identifying such
60    donor or prospective donor;
61          c.(e)Any information received by the institute in the
62    performance of its duties and responsibilities which is
63    otherwise confidential and exempt by law; and
64          d.(f)Any information received by the institute from a
65    person from this oranother state or nation or the Federal
66    Government which is otherwise exempt or confidential or exempt
67    pursuant to this or anotherthatstate's or nation's laws or
68    pursuant to federal law;
69          e. Internal auditing controls and reports of internal
70    auditors;
71          f. Contracts for managed-care arrangements, including
72    preferred provider organization contracts, health maintenance
73    organization contracts, and exclusive provider organization
74    contracts, and any documents directly relating to the
75    negotiation, performance, and implementation of any such
76    contracts for managed-care arrangements;
77          g. Bids or other contractual data, banking records, and
78    credit agreements the disclosure of which would impair the
79    efforts of the institute to contract for goods or services on
80    favorable terms;
81          h. Information relating to private contractual data, the
82    disclosure of which would impair the competitive interest of the
83    provider of the information;
84          i. Corporate officer and employee personnel information;
85          j. Information relating to the proceedings and records of
86    the credentialing panels and committees and of the governing
87    board of the institute relating to credentialing;
88          k. Minutes of meetings of the governing board of the
89    institute, except minutes of meetings open to the public
90    pursuant to subsection (10); and
91          l. Information that reveals plans for marketing services
92    that the institute reasonably expects to be provided by
93    competitors.
94         
95          As used in this subparagraph, the term "managed care” means
96    systems or techniques generally used by third-party payors or
97    their agents to affect access to and control payment for health
98    care services. Managed-care techniques most often include one or
99    more of the following: prior, concurrent, and retrospective
100    review of the medical necessity and appropriateness of services
101    or site of services; contracts with selected health care
102    providers; financial incentives or disincentives related to the
103    use of specific providers, services, or service sites;
104    controlled access to and coordination of services by a case
105    manager; and payor efforts to identify treatment alternatives
106    and modify benefit restrictions for high-cost patient care.
107          (b) The Auditor General, the Office of Program Policy
108    Analysis and Government Accountability, and the State Board of
109    Education, pursuant to their oversight and auditing functions,
110    must be given access to all proprietary confidential business
111    information upon request and without subpoena and must maintain
112    the confidentiality of information so received.
113          (c)Any governmental entity that demonstrates a need to
114    access such confidential and exempt information in order to
115    perform its duties and responsibilities shall have access to
116    such information and shall otherwise keep such information
117    confidential and exempt. This section is subject to the Open
118    Government Sunset Review Act of 1995 in accordance with s.
119    119.15 and shall stand repealed on October 2, 2006, unless
120    reviewed and saved from repeal through reenactment by the
121    Legislature.
122          (10) Meetings or portions of meetings of the governing
123    board of the Florida Alzheimer’s Center and Research Institute
124    at which information is discussed that is made confidential and
125    exempt pursuant to subsection (9) are exempt from s. 286.011 and
126    s. 24(b), Art. I of the State Constitution.
127          Section 2. Subsections (9) and (10) of s. 1004.445,
128    Florida Statutes, are subject to the Open Government Sunset
129    Review Act of 1995 in accordance with s. 119.15, Florida
130    Statutes, and shall stand repealed on October 2, 2008, unless
131    reviewed and saved from repeal through reenactment by the
132    Legislature.
133          Section 3. The Legislature finds that it is a public
134    necessity that proprietary confidential business information
135    owned or controlled by the Florida Alzheimer's Center and
136    Research Institute; internal auditing controls and reports of
137    internal auditors; contracts for managed-care arrangements and
138    any documents directly relating to the negotiation, performance,
139    and implementation of any such contracts for managed-care
140    arrangements; bids or other contractual data, banking records,
141    and credit agreements; information relating to private
142    contractual data; corporate officer and employee personnel
143    information; information relating to the proceedings and records
144    of the credentialing panels and committees and of the governing
145    board of the Florida Alzheimer's Center and Research Institute
146    relating to credentialing; minutes of meetings of the governing
147    board of the institute; and information that reveals plans for
148    marketing services that the institute reasonably expects to be
149    provided by competitors be made confidential and exempt from
150    public disclosure. The institute must compete directly with its
151    private-sector counterparts. Its economic survival depends on
152    the institute’s ability to so compete. As such, these exemptions
153    are necessary because release of such information and records
154    would adversely impact the institute in the competitive health
155    care and medical research environment. Disclosure of such
156    information and records would place the institute on an unequal
157    footing in the marketplace as compared with private health care
158    providers that are not required to disclose such confidential
159    and exempt information and records. The highly confidential
160    nature of Alzheimer-related research discoveries necessitates
161    that the institute be authorized to maintain confidential
162    information it receives from, or generates for, the sponsors of
163    its research. Accordingly, disclosure of such information and
164    records would impede the effective and efficient administration
165    of the Florida Alzheimer’s Center and Research Institute and
166    would create an unfair competitive advantage for persons or
167    entities receiving such information. Also, such information and
168    records contain information of a sensitive, personal nature
169    regarding corporate officers and employees. Disclosure of such
170    information could be harmful to the officer or employee. It is
171    likewise a public necessity that the meetings of the governing
172    board of the institute be closed in order to protect the
173    competitive interest of the institute and to guarantee the
174    ability of the governing board to fulfill its Alzheimer’s
175    disease research and teaching mission for the benefit of the
176    public. Closing access to such board meetings enables the boards
177    to be more open and frank in the information so provided and
178    discussed without the attendant fear that honest and truthful
179    exchange of information will result in the public dissemination
180    of information discussed that could be used to harm the
181    institute and its members. Furthermore, disclosing information
182    and records made confidential and exempt pursuant to the
183    institute’s public records exemption via an open meeting defeats
184    the purpose of the public records exemption.
185          Section 4. If any law amended by this act was also amended
186    by a law enacted at the 2003 Regular Session of the Legislature,
187    such laws shall be construed as if they had been enacted at the
188    same session of the Legislature, and full effect shall be given
189    to each if possible.
190          Section 5. This act shall take effect upon becoming a law.